| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 静注人免疫球蛋白(元) | 1,287,195,818.76 | 3,078,732,221.58 | 1,427,249,720.22 | 2,757,780,660.60 | 1,339,401,179.69 |
| 人血白蛋白(元) | 1,007,213,865.76 | 2,441,905,756.70 | 1,345,001,675.28 | 2,510,043,461.65 | 1,113,514,414.04 |
| 其他血液制品(元) | 291,171,423.05 | 628,398,561.13 | 328,176,756.35 | 744,927,106.24 | 377,910,613.65 |
| 营业成本(元) | |||||
| 静注人免疫球蛋白(元) | 750,814,279.19 | 1,600,501,574.96 | 716,161,890.48 | 1,187,317,750.86 | 569,339,483.26 |
| 人血白蛋白(元) | 714,073,206.44 | 1,478,047,578.80 | 793,289,242.89 | 1,224,900,446.36 | 527,467,489.77 |
| 其他血液制品(元) | 194,042,341.74 | 380,206,426.52 | 186,123,282.80 | 313,303,885.18 | 158,448,564.68 |
| 毛利(元) | |||||
| 静注人免疫球蛋白(元) | 536,381,539.57 | 1,478,230,646.62 | 711,087,829.74 | 1,570,462,909.74 | 770,061,696.43 |
| 人血白蛋白(元) | 293,140,659.32 | 963,858,177.90 | 551,712,432.39 | 1,285,143,015.29 | 586,046,924.27 |
| 其他血液制品(元) | 97,129,081.31 | 248,192,134.61 | 142,053,473.55 | 431,623,221.06 | 219,462,048.97 |
| 毛利率(%) | |||||
| 静注人免疫球蛋白(%) | 41.67 | 48.01 | 49.82 | 56.95 | 57.49 |
| 人血白蛋白(%) | 29.10 | 39.47 | 41.02 | 51.20 | 52.63 |
| 其他血液制品(%) | 33.36 | 39.50 | 43.29 | 57.94 | 58.07 |
| 收入构成(%) | |||||
| 静注人免疫球蛋白(%) | 49.78 | 50.07 | 46.03 | 45.87 | 47.31 |
| 人血白蛋白(%) | 38.96 | 39.71 | 43.38 | 41.75 | 39.34 |
| 其他血液制品(%) | 11.26 | 10.22 | 10.58 | 12.39 | 13.35 |
| 毛利构成(%) | |||||
| 静注人免疫球蛋白(%) | 57.88 | 54.95 | 50.62 | 47.77 | 48.88 |
| 人血白蛋白(%) | 31.63 | 35.83 | 39.27 | 39.10 | 37.20 |
| 其他血液制品(%) | 10.48 | 9.23 | 10.11 | 13.13 | 13.93 |